All closing conditions satisfied for the acquisition of three small molecule sites in the US and Australia; closing to occur as of May 1, 2026. Adds highly demanded US-based manufacturing capacity to Siegfried's network.
Landmark facility to produce low-carbon methanol, supporting the energy transition and creating hundreds of jobs along the Gulf Coast.
New facility serves biopharma manufacturers throughout the region with local access to customer purification studies across Ecolab's Purolite Resin portfolio
The investment, its largest since its inception, demonstrates continued progress against AbbVie's $100 billion commitment to US R&D and capital investments, including manufacturing, over the next decade.
Evonik is expanding its biotechnological production capacities at the Fermas site in Slovenská Ľupča with an investment of around €80 million
Uhde Inventa-Fischer has signed a contract with Köksan for the supply of a PET production plant. The plant will be built in Yumurtalık, Türkiye.
The acquisition marks Samsung Biologics’ geographical diversification, establishing its first US manufacturing presence and expanding regional client support.
The newly constructed Verbund site in Zhanjiang, Guangdong Province in southern China, with an area of around four square kilometers, is more than just a major project for BASF in the growth market of China.
Cambrex is advancing its $150 million investment to expand API manufacturing in Iowa and enhance R&D and manufacturing capabilities in Milan, strengthening its services in the US and Europe.
LGM Pharma invests an additional $9 million to expand US manufacturing, bringing total investment to $15 million across its Texas and Colorado facilities.
Ice Pharma recently announced a strategic expansion beyond its core API business, positioning the company to compete in higher-value finished dosage, nutraceutical, and specialty excipient markets.
Full-building, 15-year lease for 64,000 square feet enables CDMO CordenPharma Colorado to power next-generation peptide development in Boulder, Colorado.
$60 million investment to expand highly potent API (HPAPI) development and manufacturing at Axplora’s Farmabios site in Gropello Cairoli, Italy.
Arkema will increase Kynar PVDF production capacity at its Changshu, China site by 20% by 2028 to meet strong demand for batteries, coatings and other high-performance applications in Asia-Pacific and globally.
Metrohm USA opened its new 15,000 sq ft Houston facility on March 24, 2026, marking its shift from leased space to a custom-built, sustainable site supporting technical innovation, training, and regional growth.
Investment marks continued progress against AbbVie's $100 billion commitment to US R&D and capital investments, including manufacturing, over the next decade.
Ineos will invest €300 million, backed by French government grants, to modernise and decarbonise its Lavera site, cutting CO₂ emissions by 331,000 tons annually.
Syensqo is investing about €20 million, with backing from the France 2030 plan, to install a large-capacity electric boiler and other low-carbon infrastructure at its Saint-Fons site.
Axplora announced a multi-million-euro investment to expand lyophilization capabilities at its Le Mans site and appointed François Houbart as Head of Site.
BASF plans to open a global digital hub in Hyderabad in the first quarter of 2026, thereby strengthening the existing global network of digital hubs in EMEA and APAC.
Sharp Services has invested over €20 million to expand injectables packaging capacity at its facilities in Hamont-Achel, Belgium, and Heerenveen, Netherlands, with significant cold chain enhancements.
Siegfried signed binding agreements to acquire three drug substance sites in the US and Australia.
Fluor Corporation announced the mechanical completion of BASF's landmark Zhanjiang Verbund project in China.
Tjoapack is expanding its oral solid dose (OSD) bottle packaging capabilities at its Etten-Leur, Netherlands, facility, enhancing flexibility, efficiency, and GMP-compliant packaging options to meet growing demand.
Company announces two new additional manufacturing facilities to be built in North Carolina and Pennsylvania; continues to deliver on $55 billion US investment.
AbbVie will acquire West Pharmaceutical Services’ Tempe, Arizona, manufacturing facility for over $175 million to expand US drug delivery device capacity, with closing expected mid-2026.
Sharp Sterile Manufacturing announced a $28 million expansion of its Lee, Massachusetts site to boost pharmaceutical production capacity and create high-skilled life sciences jobs.
Optex Innovation Center launches as an independent extrusion coating pilot for flexible packaging.
Carbios has reaffirmed its plan to build the Longlaville PET biorecycling plant, postponing the project by about three months while it finalizes the remaining financing in the first half of 2028.
Ineos is investing £150 million at its Grangemouth site, supported by a £75 million government loan guarantee and a £50 million grant.
Fourth major US manufacturing investment announced this year, advancing AstraZeneca’s historic $50 billion commitment to medicines manufacturing and R&D.
New capacity of specialty lubricants to accelerate business growth and innovation in the region.
New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies from early research to clinical readiness.
Novartis plans to establish a flagship manufacturing hub in North Carolina by 2027-2028 as part of a $23 billion investment in US infrastructure.
Ineos has launched a major investment at Lavera to regenerate and modernize one of France’s most important industrial sites, safeguarding 10,000 jobs, with support from the French State.
